Cross Country Healthcare (CCRN)
(Real Time Quote from BATS)
$12.64 USD
-0.20 (-1.56%)
Updated Aug 6, 2025 10:56 AM ET
4-Sell of 5 4
C Value D Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CCRN 12.64 -0.20(-1.56%)
Will CCRN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CCRN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CCRN
Kforce (KFRC) Lags Q2 Earnings Estimates
Analysts Estimate Cross Country Healthcare (CCRN) to Report a Decline in Earnings: What to Look Out for
CCRN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cross Country Healthcare (CCRN) Q1 Earnings Top Estimates
Are Investors Undervaluing Cross Country Healthcare (CCRN) Right Now?
Cross Country (CCRN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for CCRN
Cross Country Healthcare (CCRN) Shares Climb Amid Acquisition Review Update
Cross Country Healthcare gains on report it likely won't be subject of FTC meeting
Cross Country Healthcare (CCRN) Shares Drop Amid FTC Meeting Concerns
Cross Country Healthcare drops amid news of FTC meeting next week
Cross Country Healthcare: At This Price, The Pending Acquisition Is Worth Betting On (Rating Upgrade)